Literature DB >> 26153296

Pulmonary aspergillosis presenting with recurrent haemoptysis.

Blas Y Betancourt1, Adrian C Garofoli1, Jagbir S Sandhu2, Noella Boma1, Alexander M Sy1.   

Abstract

Pulmonary aspergillosis presents with a variety of clinical forms including invasive pulmonary aspergillosis, chronic necrotising aspergillosis, aspergilloma, chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Haemoptysis is a devastating complication of pulmonary aspergillosis and a common indication for surgery. We report a case of a 54-year-old man with a history of pulmonary tuberculosis and diabetes mellitus, who presented with productive cough and haemoptysis for 2 months. Chest CT revealed a 30 mm diameter soft tissue mass in the upper lobe of the right lung. Haemoptysis subsided with conservative measures, but 2 weeks later the patient developed a new episode of persistent haemoptysis, which was only partially controlled with bronchial arterial embolisation. He underwent right upper and middle lobectomy. Histology examination confirmed the presence of a fungal cavitary lesion. The patient was started on voriconazole, and recovered with no recurrence at 18 months follow-up. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153296      PMCID: PMC4499746          DOI: 10.1136/bcr-2015-211249

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Pulmonary aspergillosis: recent advances.

Authors:  George R Thompson; Thomas F Patterson
Journal:  Semin Respir Crit Care Med       Date:  2011-12-13       Impact factor: 3.119

2.  Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.

Authors:  David W Denning; Alex Pleuvry; Donald C Cole
Journal:  Bull World Health Organ       Date:  2011-09-27       Impact factor: 9.408

3.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

4.  Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma.

Authors:  N L Smith; D W Denning
Journal:  Eur Respir J       Date:  2010-07-01       Impact factor: 16.671

5.  Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment.

Authors:  J Jewkes; P H Kay; M Paneth; K M Citron
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

6.  Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience.

Authors:  Shakil Farid; Shaza Mohamed; Mohan Devbhandari; Matthew Kneale; Malcolm Richardson; Sing Y Soon; Mark T Jones; Piotr Krysiak; Rajesh Shah; David W Denning; Kandadai Rammohan
Journal:  J Cardiothorac Surg       Date:  2013-08-05       Impact factor: 1.637

  6 in total
  1 in total

Review 1.  The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach.

Authors:  Firas Maghrabi; David W Denning
Journal:  Curr Fungal Infect Rep       Date:  2017-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.